Amgen
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
The next goal for weight loss drugs? Fewer injections
For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss. It may be fewer injections. Pfizer and Amgen are developing monthly GLP-1 shots — a departure from injections like Wegovy and Zepbound, which are taken weekly.
Platner’s anti-corporate crusade hits awkward snag as receipts tell another story
Maine Democratic Senate candidate Graham Platner built a national reputation as an anti-corporate crusader while cashing checks written by lobbyists and executives representing those same corporations, campaign finance documents show. Platner has made criticism of big tech, the pharmaceutical industry, large banks and defense contractors a cornerstone of his campaign to unseat incumbent GOP Sen. Susan Collins. Federal Election Commission and Lobbying Disclosure Act records reviewed by Fox...
Quantinuum stock opens at $68 per share after IPO
Quantinuum opened trading at $68 per share on the Nasdaq on Thursday, after upsizing its initial offering. The company raised $1.68 billion in an upsized IPO after it priced at $60 per share, above its earlier range of $53 to $55 per share. At the first trade price, Quantinuum has a market cap of about $17.6 billion.
Platner’s anti-corporate crusade hits awkward snag as receipts tell another story
Maine Democratic Senate candidate Graham Platner built a national reputation as an anti-corporate crusader while cashing checks written by lobbyists and executives representing those same corporations, campaign finance documents show. Platner has made criticism of big tech, the pharmaceutical industry, large banks and defense contractors a cornerstone of his campaign to unseat incumbent GOP Sen. Susan Collins. Federal Election Commission and Lobbying Disclosure Act records reviewed by Fox...